EKALAK YODCHAI: Open Payments
NPI 1609395383 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 20 payments from 4 companies in 2025. Trend: 2023 $16 · 2024 $307 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $414 |
| Otsuka America Pharmaceutical, Inc. | 8 | $272 |
| Janssen Pharmaceuticals, Inc | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: REXULTI, LYBALVI, ARISTADA, SPRAVATO, ABILIFY MAINTENA, TRINTELLIX.
Industry payments across IL — which companies pay providers there.
